In this study, we integrated a series of public bioinformatic analysis to explore the mRNA and protein profiles of FDX1 across human cancers and cell lines and validated its expression and prognostic value, especially in ccRCC. This evidence concerns the gene FDX1 and nonpapillary renal cell carcinoma.